Raft-Dependent Endocytosis of Autocrine Motility Factor/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor Cells
Author Information
Author(s): Kojic Liliana D., Wiseman Sam M., Ghaidi Fariba, Joshi Bharat, Nedev Hinyu, Saragovi H. Uri, Nabi Ivan R.
Primary Institution: University of British Columbia
Hypothesis
The study investigates whether raft-dependent endocytosis of AMF/PGI can serve as a tumor cell-specific targeting mechanism for drug delivery.
Conclusion
The raft-dependent endocytosis of AMF/PGI may represent a tumor cell specific endocytic pathway of potential value for drug delivery to tumor cells.
Supporting Evidence
- Raft-dependent endocytosis of AMF/PGI is increased in metastatic cancer cells.
- AMF/PGI-paclitaxel conjugate shows similar cytotoxicity to free paclitaxel in tumor cells that internalize AMF/PGI.
- Intratumoral injection of AMF/PGI-paclitaxel induces significant tumor regression compared to free paclitaxel.
- AMF/PGI-paclitaxel significantly prolongs median survival time of tumor-bearing mice.
Takeaway
This study shows that a special pathway in cancer cells can help deliver drugs directly to tumors, making treatment more effective.
Methodology
The study utilized flow cytometry to analyze the endocytosis of AMF/PGI in various cancer cell lines and assessed the efficacy of an AMF/PGI-paclitaxel conjugate in vitro and in vivo.
Limitations
The study primarily focuses on specific cancer cell lines and may not fully represent all tumor types.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website